Unitaid Calls For More Funding for COVID-19 Therapy Research and Development

The Access to COVID-19 Tools (ACT) Accelerator is a global cooperation aimed at speeding up the development, manufacture, and distribution of COVID-19 tests, treatments, and vaccines.

Unitaid Executive Director Dr Philippe Duneton, who co-leads the ACT-Therapeutics Accelerator’s partnership, has warned that vaccines cannot be the only tool we use to combat the pandemic, emphasising the importance of investing in all available tools to combat the pandemic, including tests, treatments, and health system support.

The majority of COVID-19 drug research is conducted in high-income nations, which limits the development and testing of medications that are appropriate for lower-income countries. However, in collaboration with the German government, Unitaid has invested in the ANTICOV platform trial of COVID-19 medications tailored to the needs of low- and middle-income nations. The trial will look at a medicine combination that will treat mild-to-moderate instances in the hopes of preventing them from becoming critical.

UN Permanent Representative of Israel Briefs Press

Danny Danon, Permanent Representative of Israel to the United Nations, briefs reporters on the situation in Lebanon.

Web Cache Poisoning

A cyber attack known as ” web cache poisoning” uses cache storage systems to propagate malicious data to unsuspecting users.When an attacker is successful in poisoning a cache, they can change the content that users receive by sending them to fake websites, plating malware, or stealing personal data.